Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region by G.B. Migliori, O. Korotych, J. Achar, A. Ciobanu, G. Dravniece, M. Germanovych, E. Gurbanova, A. Hovhannesyan, N. Khachatryan, L. Kuksa, N. Lomtadze, M.L. Rich, A. Skrahina, A. Yedilbayev

Get full text

Clinical best practices for caring for people with expanded resistance to newer TB drugs by T. Nkomo, Z. Udwadia, D. Vambe, A. van Rie, S.S. Thi, J. Stillo, A. Stambekova, A. Sinha, M.L. Rich, A. Reuter, J. Patel, R. Otto-Knapp, I. Motta, A. Mesic, L. McKenna, S. Maru, E. Lessem, C. Lange, N. Kiria, Y. Kherabi, G. Günther, L. Guglielmetti, T. Decroo, L. Chen, A. Ashesh, A. Abubakirov, J. Furin

Get full text

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB by C. Zeng, M.A. Hernán, L. Trevisi, S. Sauer, C.D. Mitnick, C. Hewison, M. Bastard, P. Khan, K.J. Seung, M.L. Rich, S. Law, M. Kikvidze, O. Kirakosyan, A. Miankou, P. Thit, S. Mamsa, A. Janmohamed, N. Melikyan, S. Ahmed, D. Vargas, A.B. Binegdie, K. Temirova, L. Oyewusi, K. Philippe, S.C. Vilbrun, U. Khan, H. Huerga, M.F. Franke, on behalf of the endTB Observational Study Team

Get full text